Clinical Trials in Chicago

Showing 1901-1920 of 17,609 trials

Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines

NCT07142369

The purpose of this study is to determine what effects the withdrawal of excess knee joint fluid or the injection of a factor from the blood has on swelling after a sudden anterior cruciate ligament (ACL) rupture of the knee.

Posttraumatic OsteoarthritisAnterior Cruciate Ligament (ACL) Rupture

Rush University Medical Center99 participantsStarted May 2026

Chicago, Illinois, United States

RECRUITINGPhase 32.2 miles

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

NCT06627647

The purpose of ARTEMIDE-Lung03 is to evaluate the efficacy and safety of rilvegostomig compared to pembrolizumab, both in combination with platinum-based doublet chemotherapy, as a first-line treatment of patients with non-squamous mNSCLC whose tumors express PD-L1.

Non-squamous Non-small Cell Lung Cancer

AstraZeneca878 participantsStarted Nov 2024

Mobile, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +279 more locations

Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

Find Trials by Condition in Chicago

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

A Study of AZD0120 in Autoimmune Diseases

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer

A Study of Navenibart in Participants With Hereditary Angioedema

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy